Skip to main content

Melodiol Global Health Ltd. Health Care

$0.007 (0%)

High

$0.01

Low

$0.01

Trades

47

Turnover

$23,686

Volume

3,636,136
30 June 2023 at 4:10pm
Register to track ME1 and receive email alerts.

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Expand Company Description

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Information on this page was last updated around 10 October 2024.

Stock Information

Code

ME1

Name

Melodiol Global Health Ltd.

Country

AU

Currency

AUD

GIC Sector

Health Care

GIC Group

Pharmaceuticals, Biotechnology & Life Sciences

GIC Industry

Pharmaceuticals

GIC Sub Industry

Pharmaceuticals

Sector

Healthcare

IPO Date

N/A

Fiscal Year

December

Type

Common Stock

Shares Outstanding

1,125,830,016

Shares Floated

13,058,603

Held by Insiders

0.312%

Held by Institutions

0%

Technicals

52w High

$4.20

52w Low

$0.00

50D MA

$0.00

200D MA

$0.07

Financial Snapshot (June 2023)

Market Cap (10-Oct)

$1,125,830

EBITDA

-

PE

0.00

Book Value

$-0.52

Dividend per Share

N/A

Dividend Yield

N/A

EPS

$-7.64

Profit Margin

N/A

Operating Margin

-80.32%

ROA

33.31%

ROE

389.56%

Revenue (FY)

$18,921,000

Revenue per Share

$4.07

Gross Profit (FY)

$0

Q' YOY Revenue Growth

-

Q' YOY Earnings Growth

-

Directors & Officers

Name & Education Position

Mr. Boaz Wachtel M.A., M.D., MBA

Co-Founder & Non-Executive Chairman

Mr. William Lay B.Com.

Group CEO, MD & Director

Mr. Christopher Grundy BCom, FCA, FCIS, GAICD

Chief Financial Officer

Ms. Micheline MacKay B.Sc., M.Sc., P.M.P.

Executive Director

Dr. Gian Trepp

Commercial & Marketing Director

Mr. Mitchel Fleming

Managing Director of Halucenex

Brett Ayers

Managing Director of Impactive

Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom

Joint Company Secretary

Hon. Brian Walker

Strategic Consultant & Chair of Scientific Advisory Committee

ME1 Historic Dividends

Date Amount
We found no dividends on record for ME1.
Register to track ME1 and receive email alerts.